Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.
from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n
Subscribe to:
Post Comments (Atom)
-
In a short span of time, Nothing has come a long way, and it now actually stands for something. The company makes good mid-range and upper m...
-
Rocket Lab has confirmed that its reusable Neutron rocket is set for its first launch in the latter half of 2025. The announcement was made ...
-
Elon Musk's X social media platform is unlikely to be subjected to landmark EU tech rules which aim to rein in the power of Big Tech b...
No comments:
Post a Comment